MedTrace Logo

Effect of Coenzyme Q10 Administration on Polycystic Ovary Syndrome

NCT06659406 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2024-10-26

No results posted yet for this study

Summary

The goal of this clinical trial is to determine the effects of coenzyme Q10 supplementation on oxidative stress, inflammation and hyperandrogenism in women with polycystic ovary syndrome. The main questions it aims to answer are:

Does Coenzyme Q10 alter oxidative stress, inflammation and hyperandrogenism in women with Polycystic ovary syndrome.

Participants will take Coenzyme Q10 200mg, once daily for a period of 3 months. The participants will be reassessed after 12 weeks by measuring Malondialdehyde MDA, C-reactive protein CRP, Sex hormone binding globulin SHBG.

Conditions

  • Polycystic Ovarian Syndrome (PCOS)

Interventions

DIETARY_SUPPLEMENT

Coenzyme Q10

Coenzyme Q10 will be given once daily, 200mg for the period of 3 months

Sponsors & Collaborators

  • College of Physicians and Surgeons Pakistan

    collaborator OTHER

  • University of Faisalabad

    lead OTHER

Principal Investigators

  • Sana Akram, MBBS, FCPS · University of Faisalabad

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-01
Primary Completion
2025-04-30
Completion
2025-12-31

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06659406 on ClinicalTrials.gov